Inadequate cervical smear: What do we do?

Acta Obstetricia et Gynecologica Scandinavica

Volumn 84, Issue 5, 2005, Pages 486-488

  Phadnis, Saurabh V ^a   Doshi, Jagruti S ^a   Ogunnaike, Oluyemisi O ^a   Padwick, Malcolm L ^a   Sanusi, F A ^b  

^a WATFORD GENERAL HOSPITAL   (United Kingdom)

^b Hemel Hempstead General Hospital   (United Kingdom)

Author keywords

Cervix; Colposcopy; Smear

Indexed keywords

ADULT; ARTICLE; COLPOSCOPY; FEMALE; HEALTH PROGRAM; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MASS SCREENING; PAPILLOMA VIRUS; PREVALENCE; PRIORITY JOURNAL; UNITED KINGDOM; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS INFECTION;

ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; FALSE NEGATIVE REACTIONS; FEMALE; GREAT BRITAIN; HUMANS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; STATE MEDICINE; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; WOMEN'S HEALTH SERVICES;

EID: 18644367816     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0001-6349.2005.00768.x     Document Type: Article

References (8)

1. Johnson J, Patnick J (eds): Achievable standards, benchmarks for reporting, and criteria for evaluating cervical cytopathology, second edition including performance indicators. NHSCSP Publication No. 1. Sheffield: NHSCSP Publications, 2000: 1-36.
2. Holland CR, Smith NA, Barton SE. An audit of inadequate cervical cytology in a genitourinary medicine clinic. Int J STD AIDS 1996; 7: 525-7.
3. Statistical Bulletin 2003/24. Cervical screening programme. London: Department of Health, 2002-2003: 6-34.
4. Hollingworth J, Kotecha K, Dobbs SP, Shaw PA, Ireland D. Cervical disease in women referred to colposcopy following inadequate smears. Cytopathology 2000; 11: 45-52.
5. Hock YL, Ramaiah S, Wall ES et al. Outcome of women with inadequate cervical smears followed up for five years. J Clin Pathol 2003; 56: 592-5.
6. Josefsson AM, Magnusson PK, Ylitalo N et al. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: nested case-control study. Lancet 2000; 355: 2179-80.
7. Chow V, Tham KM, Yeo-Gloss M et al. Molecular diagnosis of genital HPV DNA types by polymerase chain reaction and sensitivity-standardized filter in situ hybridization in randomly sampled cohorts of Singapore women. Mol Cell Probes 1990; 4: 121-31.
8. Moss SM, Gray A, Legood R, Henstock E. Evaluation of HPV/LBC cervical screening pilot studies. Department of Health: London 2003: 1-96.